EVIDENCE-BASEDAWAITING CLINICIAN REVIEW

Niacin (nicotinic acid)

WHO ATCC10AD02INNNicotinic acid

Niacin, or nicotinic acid, is vitamin B3 and can also be used as a prescription lipid-modifying drug at much higher doses than nutritional requirements. It should not be confused with nicotinamide, which has different pharmacologic effects, or with over-the-counter supplements used without lipid monitoring.

At a glance

Quick facts

Drug snapshot
Drug class
Vitamin B3; lipid-modifying drug at pharmacologic doses
Main uses
Treatment/prevention of niacin deficiency; selected dyslipidaemia indications at prescription doses when clinically appropriate
Route
Oral
WHO ATC
C10AD02
Key safety
Flushing, itching, gastrointestinal upset, liver injury, hyperglycaemia and hyperuricaemia; extended-release and immediate-release products are not dose-for-dose interchangeable.
Monitoring
Liver tests, glucose, uric acid, lipid response, product formulation and other lipid-lowering medicines.

Names & terminology

How this medicine may be named or searched

Canonical page name
Niacin (nicotinic acid)
INN / generic name
Nicotinic acid
Aliases / salts
niacin · nicotinic acid · vitamin B3
Russian support entity
nicotinic-acid.ru — entity relationship only, not a clinical source

Structured drug profile

Drug profile

INN data
INNNicotinic acidInternational nonproprietary / generic name used for this entity.
WHO ATCC10AD02Anatomical Therapeutic Chemical classification; route-specific codes may differ for some medicines.
Drug classVitamin B3; lipid-modifying drug at pharmacologic dosesPharmacologic / therapeutic class.
MechanismActs as vitamin B3 at nutritional doses; at pharmacologic doses it modifies hepatic lipid metabolism and lowers triglycerides and LDL while raising HDL, though cardiovascular benefit depends on treatment context.Mechanism summarized at reference level.
RouteOralAvailable routes depend on the specific product.
Main usesTreatment/prevention of niacin deficiency; selected dyslipidaemia indications at prescription doses when clinically appropriateApproved indications can differ by country and formulation.
Key safety contextFlushing, itching, gastrointestinal upset, liver injury, hyperglycaemia and hyperuricaemia; extended-release and immediate-release products are not dose-for-dose interchangeable.Check exact product labeling and patient-specific contraindications.
Monitoring / reviewLiver tests, glucose, uric acid, lipid response, product formulation and other lipid-lowering medicines.Monitoring depends on indication, dose, route and patient factors.

What is Niacin (nicotinic acid)?

Niacin, or nicotinic acid, is vitamin B3 and can also be used as a prescription lipid-modifying drug at much higher doses than nutritional requirements. It should not be confused with nicotinamide, which has different pharmacologic effects, or with over-the-counter supplements used without lipid monitoring.

What is Niacin (nicotinic acid) used for?

Treatment/prevention of niacin deficiency; selected dyslipidaemia indications at prescription doses when clinically appropriate. The exact approved indication depends on the product, route and country. [1]

How it works

Acts as vitamin B3 at nutritional doses; at pharmacologic doses it modifies hepatic lipid metabolism and lowers triglycerides and LDL while raising HDL, though cardiovascular benefit depends on treatment context.

Forms and formulations

Immediate-release and extended-release tablets; supplement forms also exist. Different formulations may have different indications, strengths, excipients and instructions and should not be assumed interchangeable.

Country / market layer

Availability and formulations by market

Brand names, strengths, prescription status and approved uses vary by jurisdiction. Check the exact national product record before relying on a formulation.

Market-specific
🇬🇧
United KingdomSearch current eMC product information
Search eMC ↗

Availability depends on the active ingredient, route and formulation; not every medicine in this reference has a current UK product.

This English reference was selected because DiseasesConditions.org also maintains an entity relationship to the project’s Russian-language support site nicotinic-acid.ru. The Russian site is not used as a clinical source for this page.

How it is used

Prescription niacin should be taken exactly as the formulation label specifies. Immediate-release and extended-release products have different schedules and safety profiles. Switching formulations without medical supervision can substantially change exposure and liver risk.

For prescription treatment, use the patient-specific regimen rather than copying a dose from another person or another formulation.

Side effects

Flushing, warmth, itching and headache are common, especially early in treatment. Higher therapeutic doses can also cause gastrointestinal effects, raise blood glucose and uric acid, and injure the liver.

Important warnings and monitoring

Seek medical assessment for jaundice, dark urine, severe weakness, unexplained muscle pain or significant glucose deterioration. People with active liver disease, significant gout or heavy alcohol use need careful review before pharmacologic-dose niacin.

Monitoring context: Liver tests, glucose, uric acid, lipid response, product formulation and other lipid-lowering medicines.

Interactions

Statins and other lipid medicines can increase muscle-toxicity risk in some combinations. Alcohol can worsen flushing and liver risk. Bile-acid sequestrants can interfere with absorption if taken too close together.

Pregnancy and breastfeeding

Nutritional vitamin requirements and prescription lipid-lowering doses are very different. Pharmacologic-dose niacin in pregnancy should only be used after specialist assessment of indication and alternatives.

Overdose and accidental extra doses

Excessive doses can cause marked flushing, low blood pressure, gastrointestinal symptoms, metabolic disturbance and liver toxicity. Significant overdose requires poison-centre or emergency advice.

Practical clinical context

The most important distinction is between the medicine entity and a specific marketed product. Strength, salt, route, modified-release design, age authorization and prescription status can change between products. When safety or dosing decisions matter, use the exact package leaflet, prescribing information or national regulator record for the product actually being used.

This page deliberately separates general evidence from the project’s Russian-language support site nicotinic-acid.ru; that site identifies the cross-language entity but is not treated as an authority for clinical claims.

Common questions

Frequently asked questions

AWAITING CLINICIAN REVIEW

Sources

Clinical statements in this reference are based on named public-health, regulatory or guideline sources. Product-specific labeling remains authoritative for exact indications, dosing and contraindications.

  1. 1. MedlinePlus. Niacin Drug Information. Source ↗
  2. 2. MedlinePlus. Niacin for cholesterol. Source ↗

This medicine reference is evidence-based and is awaiting clinician review. It is not a substitute for personalized medical advice.